Milestone Pharmaceuticals announced appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer. effective February 15, 2022. Dr. Bharucha most recently served as Vice President, Research and Development, Clinical Development at Allergan, a division of AbbVie.

He will replace Francis Plat, M.D., who will transition to Chief Scientific Officer of the Company and, following the completion of the Phase 3 RAPID trial in the second half of 2022, will serve in an advisory capacity.